Wolf Popper LLP Investigates Claims That the Proposed Acquisition of Liberator Medical Holdings, Inc. May Not Be In the Best Interests of Its Investors

Nov 20, 2015, 10:06 ET from Wolf Popper LLP

NEW YORK, Nov. 20, 2015 /PRNewswire/ -- Wolf Popper LLP is investigating claims on behalf of investors in Liberator Medical Holdings, Inc. ("Liberator Medical") (NYSE: LBMH), concerning the proposed acquisition of Liberator Medical by C.R. Bard, Inc. (NYSE: BCR).  Liberator Medical shareholders seeking more information about this acquisition can contact Carl L. Stine at (212) 759-4600 or cstine@wolfpopper.com.

The investigation concerns whether Liberator Medical's directors are breaching their fiduciary duties by failing to adequately maximize shareholder value.  Under the terms of the proposed transaction, Liberator Medical's shareholders will receive $3.35 per share in cash for each Liberator Medical share they own.  However, the offer price is below the 52-week high of $3.87 per share and below an analyst price target of $8.00 per share.    

Wolf Popper LLP has extensive experience representing investors in mergers and acquisition lawsuits and has successfully ensured that investors receive the maximum compensation.  Twelve Wolf Popper attorneys were named Rising Stars or Super Lawyers in the 2015 Super Lawyers New York City Metro Edition, including Wolf Popper partner Carl Stine, who was included in the Super Lawyers Top 100 List for the New York City Metro area.  View Wolf Popper attorney biographies at www.wolfpopper.com.

Attorney Advertising: Prior Results Do Not Guarantee A Similar Outcome.

Wolf Popper LLP 845 Third Avenue New York, New York 10022 Telephone: 212-759-4600 Toll Free Tel: 877-370-7703 Toll Free Fax: 877-370-7704 Email: cstine@wolfpopper.com


SOURCE Wolf Popper LLP